Molecule Details
| InChIKey | YRVIKLBSVVNSHF-JTQLQIEISA-N |
|---|---|
| Compound Name | Pozanicline |
| Canonical SMILES | Cc1ncccc1OC[C@@H]1CCCN1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.58 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB05458 |
|---|---|
| Drug Name | Pozanicline |
| CAS Number | 161417-03-4 |
| Groups | investigational |
| ATC Codes | nan |
| Description | ABT-089 is a neuronal nicotinic acetylcholine receptor agonist that may have therapeutic utility for the treatment of several neurological disorders including Alzheimer, Attention Deficit Hyperactivity Disorder and Schizophrenia/Schizoaffective disorders. In radioligand binding studies, ABT-089 has ... |
Cross-references: BindingDB: 50056147 CHEMBL127071 ChemSpider: 155000 PubChem:178052 PubChem:175427009 Wikipedia: Pozanicline ZINC: ZINC000000006562